Vascular adverse events
| Age/sex . | Adverse event . | CV risk factors . | Previous nilotinib? . |
|---|---|---|---|
| 62/F | Newly diagnosed IHD | HTN, dyslipidemia, ex-smoker | No |
| 63/M | PVD requiring surgery | None | Yes |
| 61/M | Ischemic CVA, pericardial effusion | HTN, DM, ex-smoker | Yes |
| 64/F | Elective AAA repair | Previous IHD, ex-smoker | No |
| 65/M | AF, pericardial effusion (in setting of sepsis) | Ex-smoker | Yes |
| 47/F | PVD requiring surgery, complicated by NSTEMI | HTN, DM, dyslipidemia, ex-smoker | Yes |
| 63/F | Ischemic CVA | DM, HTN, ex-smoker | No |
| 65/M | Newly diagnosed IHD | DM, HTN | No |
| Age/sex . | Adverse event . | CV risk factors . | Previous nilotinib? . |
|---|---|---|---|
| 62/F | Newly diagnosed IHD | HTN, dyslipidemia, ex-smoker | No |
| 63/M | PVD requiring surgery | None | Yes |
| 61/M | Ischemic CVA, pericardial effusion | HTN, DM, ex-smoker | Yes |
| 64/F | Elective AAA repair | Previous IHD, ex-smoker | No |
| 65/M | AF, pericardial effusion (in setting of sepsis) | Ex-smoker | Yes |
| 47/F | PVD requiring surgery, complicated by NSTEMI | HTN, DM, dyslipidemia, ex-smoker | Yes |
| 63/F | Ischemic CVA | DM, HTN, ex-smoker | No |
| 65/M | Newly diagnosed IHD | DM, HTN | No |
AAA, aortoabdominal aneurysm; AF, atrial fibrillation; CV, cardiovascular; CVA, cerebrovascular accident; DM, diabetes mellitus; HTN, hypertension; IHD, ischemic heart disease; NSTEMI, non-ST elevated myocardial infarction; PVD, peripheral vascular disease.